OncoPharm

Latest Episodes:

Axitinib's Big Weekend Feb 21, 2019

Show notes

Axitinib studies presented at ASCO-GU '19 with simultaneous NEJM publication are discussed, followed by a brief overview (18:50) of darolutamide, a new anti-androgen, and its drug interaction potential.

IRIS Feb 14, 2019

Show notes

The Landmarks in Oncology Pharmacy series returns to discuss the International Randomized Study of Interferon vs. STI571 (imatinib) aka IRIS.

Cannabidiol (CBD) & Potential Drug Interactions In Cancer Patients Feb 07, 2019

Show notes

CBD use is becoming more widespread in society, including in cancer patients. Potential, and significant, drug interaction concerns should be considered.

Mucositis & Stomatitis Jan 31, 2019

Show notes

Mucositis & stomatitis are basically interchangeable terms for one of the hallmark chemotherapy toxicities. We discuss its pathophysiology, prevalent, and prevention/treatment.

Olaratumab, Goodbye? Jan 24, 2019

Show notes

Olaratumab received accelerated approval in 2016 under the condition a phase III study would confirm its benefit. It didn't. We explore some possible explanations why a seemingly promising drug for a tough disease hasn't panned out...

Conversation With An Osteosarcoma Survivor Jan 17, 2019

Show notes

It's always enlightening to talk to a cancer survivor and is an essential part of the patient care process. This conversation touches on chemo-induced toxicities (e.g. ifosfamide neurotoxicity), supportive care advances (olanzapine!), and the anxiety of survivors live with while living scan-to-scan. Brought to you by the Bill Gatton College of Pharmacy.

New & Niche Drugs Jan 10, 2019

Show notes

We finish discussing the 2018 FDA-approvals (calaspargase, ravulizumab, tazgraxofusp).

mFOLFIRINOX Jan 03, 2019

Show notes

New year, new chemo regimen to discuss. We go over mFOLFIRINOX for adjuvant pancreatic cancer from the recently published PRODIGE-24 study. We discuss out the regimen is modified, where to find dose reductions, and how many patients required G-CSF.

Let's Talk About Mr. Gower Dec 20, 2018

Show notes

Keeping it light this Holiday Season with a discussion of the portrayal of pharmacists, notably Mr. Gower from It's a Wonderful Life, in pop culture. Regular Pods return in 2019.

FOLFOX (MOSAIC Trial) Dec 13, 2018

Show notes

The Landmarks in Oncology Pharmacy series returns with a discussion of MOSAIC: FOLFOX adjuvant chemotherapy for stage ii & STAGE III colon cancer.

Our TOPPODCAST Picks

Follow Us

Stay Connected

Related Podcasts

Links

Stay Connected